Skip to main content
Erschienen in: Current Diabetes Reports 2/2012

01.04.2012 | Pathogenesis of Type 2 Diabetes and Insulin Resistance (R Watanabe, Section Editor)

A Synergy between Incretin Effect and Intestinal Gluconeogenesis Accounting for the Rapid Metabolic Benefits of Gastric Bypass Surgery

verfasst von: Gilles Mithieux

Erschienen in: Current Diabetes Reports | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

The early improvement of glucose control taking place shortly after gastric bypass surgery in obese diabetic patients has long been mysterious. A recent study in mice has highlighted some specific mechanisms underlying this phenomenon. The specificity of gastric bypass in obese diabetic mice relates to major changes in the sensations of hunger and to rapid improvement of glucose parameters. The induction of intestinal gluconeogenesis plays a major role in diminishing hunger, and in restoring insulin sensitivity of endogenous glucose production. In parallel, the restoration of the secretion of glucagon-like peptide 1 and insulin plays a key additional role, in this context of recovered insulin sensitivity, to improve postprandial glucose tolerance. Therefore, a synergy between an incretin effect and intestinal gluconeogenesis is a key feature accounting for the rapid improvement of glucose control in obese diabetic patients after bypass surgery.
Literatur
1.
Zurück zum Zitat • Thaler JP, Cummings DE. Minireview: hormonal and metabolic mechanism of diabetes remission after gastrointestinal surgery. Endocrinology. 2009;150:2518–2525. This is a comprehensive review relating to metabolic surgery and its possible underlying mechanisms. PubMedCrossRef • Thaler JP, Cummings DE. Minireview: hormonal and metabolic mechanism of diabetes remission after gastrointestinal surgery. Endocrinology. 2009;150:2518–2525. This is a comprehensive review relating to metabolic surgery and its possible underlying mechanisms. PubMedCrossRef
2.
Zurück zum Zitat Korner J, Bessler M, Cirilo LJ, et al. Effects or Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab. 2005;90:359–65.PubMedCrossRef Korner J, Bessler M, Cirilo LJ, et al. Effects or Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab. 2005;90:359–65.PubMedCrossRef
3.
Zurück zum Zitat Reinehr T, Roth CL, Schernthaner GH, et al. Peptide YY and glucagon-like peptide-1 in morbidly obese patients before and after surgically induced weight loss. Obes Surg. 2007;17:1571–7.PubMedCrossRef Reinehr T, Roth CL, Schernthaner GH, et al. Peptide YY and glucagon-like peptide-1 in morbidly obese patients before and after surgically induced weight loss. Obes Surg. 2007;17:1571–7.PubMedCrossRef
4.
Zurück zum Zitat le Roux CW, Welbourn R, Werling M, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg. 2007;246:780–5.PubMedCrossRef le Roux CW, Welbourn R, Werling M, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg. 2007;246:780–5.PubMedCrossRef
5.
Zurück zum Zitat Perez-Tilve D, D’Alessio DA, Tschöp MH. A sweet spot for the bariatric surgeon. Cell Metab. 2008;8:177–9.PubMedCrossRef Perez-Tilve D, D’Alessio DA, Tschöp MH. A sweet spot for the bariatric surgeon. Cell Metab. 2008;8:177–9.PubMedCrossRef
6.
Zurück zum Zitat •• Troy S, M Soty, Ribeiro L, et al. Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not gastric after lap-band in mice. Cell Metab. 2008;8:201–211. This is a mechanistic study highlighting the role of IGNG in the modulation of hunger and restoration of hepatic insulin sensitivity shortly after gastric bypass in obese diabetic mice. PubMedCrossRef •• Troy S, M Soty, Ribeiro L, et al. Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not gastric after lap-band in mice. Cell Metab. 2008;8:201–211. This is a mechanistic study highlighting the role of IGNG in the modulation of hunger and restoration of hepatic insulin sensitivity shortly after gastric bypass in obese diabetic mice. PubMedCrossRef
7.
Zurück zum Zitat Tordoff MG, Tluczek JP, Friedman MJ. Effect of hepatic portal glucose concentration on food intake and metabolism. Am J Physiol. 1989;257:R1474–80.PubMed Tordoff MG, Tluczek JP, Friedman MJ. Effect of hepatic portal glucose concentration on food intake and metabolism. Am J Physiol. 1989;257:R1474–80.PubMed
8.
Zurück zum Zitat Shimizu N, Oomura Y, Novin D, et al. Functional correlations between lateral hypothalamic glucose-sensitive neurons and hepatic portal glucose-sensitive units in rat. Brain Res. 1983;265:49–54.PubMedCrossRef Shimizu N, Oomura Y, Novin D, et al. Functional correlations between lateral hypothalamic glucose-sensitive neurons and hepatic portal glucose-sensitive units in rat. Brain Res. 1983;265:49–54.PubMedCrossRef
9.
Zurück zum Zitat Croset M, Rajas F, Zitoun C, et al. Rat small intestine is an insulin-sensitive gluconeogenic organ. Diabetes. 2001;50:740–6.PubMedCrossRef Croset M, Rajas F, Zitoun C, et al. Rat small intestine is an insulin-sensitive gluconeogenic organ. Diabetes. 2001;50:740–6.PubMedCrossRef
10.
Zurück zum Zitat • Delaere F, Magnan C, Mithieux G. Hypothalamic integration of portal glucose signals and control of food intake and insulin sensitivity. Diabetes Metabol. 2010;36:257–262. This is a recent review on the integration of portal glucose signals at a hypothalamic level and their consequences on the sensation of hunger and hepatic glucose metabolism. CrossRef • Delaere F, Magnan C, Mithieux G. Hypothalamic integration of portal glucose signals and control of food intake and insulin sensitivity. Diabetes Metabol. 2010;36:257–262. This is a recent review on the integration of portal glucose signals at a hypothalamic level and their consequences on the sensation of hunger and hepatic glucose metabolism. CrossRef
11.
Zurück zum Zitat Mithieux G, Misery P, Magnan C, et al. Portal sensing of intestinal gluconeogenesis is a mechanistic link in the reduction of food intake induced by diet protein. Cell Metab. 2005;2:321–9.PubMedCrossRef Mithieux G, Misery P, Magnan C, et al. Portal sensing of intestinal gluconeogenesis is a mechanistic link in the reduction of food intake induced by diet protein. Cell Metab. 2005;2:321–9.PubMedCrossRef
12.
Zurück zum Zitat Rajas F, Bruni N, Montano S, et al. The glucose-6 phosphatase gene is expressed in human and rat small intestine: regulation of expression in fasted and diabetic rats. Gastroenterology. 1999;117:132–9.PubMedCrossRef Rajas F, Bruni N, Montano S, et al. The glucose-6 phosphatase gene is expressed in human and rat small intestine: regulation of expression in fasted and diabetic rats. Gastroenterology. 1999;117:132–9.PubMedCrossRef
13.
Zurück zum Zitat Mithieux G, Bady I, Gautier A, et al. Induction of control genes in intestinal gluconeogenesis is sequential during fasting and maximal in diabetes. Am J Physiol Endocrinol Metab. 2004;286:E370–5.PubMedCrossRef Mithieux G, Bady I, Gautier A, et al. Induction of control genes in intestinal gluconeogenesis is sequential during fasting and maximal in diabetes. Am J Physiol Endocrinol Metab. 2004;286:E370–5.PubMedCrossRef
14.
Zurück zum Zitat Mithieux G, Rajas F, Gautier-Stein A. A novel role for glucose-6 phosphatase in the small intestine in the control of glucose homeostasis. J Biol Chem. 2004;279:44231–4.PubMedCrossRef Mithieux G, Rajas F, Gautier-Stein A. A novel role for glucose-6 phosphatase in the small intestine in the control of glucose homeostasis. J Biol Chem. 2004;279:44231–4.PubMedCrossRef
15.
Zurück zum Zitat Burcelin R, Dolci W, Thorens B. Glucose sensing by the hepatoportal is GLUT2-dependent: in vivo analysis in GLUT2-null mice. Diabetes. 2000;49:1643–8.PubMedCrossRef Burcelin R, Dolci W, Thorens B. Glucose sensing by the hepatoportal is GLUT2-dependent: in vivo analysis in GLUT2-null mice. Diabetes. 2000;49:1643–8.PubMedCrossRef
16.
Zurück zum Zitat Cardin S, Emshwiller M, Jackson PA, Snead WL, Hastings J, Edgerton DS, et al. Portal glucose infusion increases hepatic glycogen deposition in conscious unrestrained rats. J Appl Physiol. 1999;87:1470–5.PubMed Cardin S, Emshwiller M, Jackson PA, Snead WL, Hastings J, Edgerton DS, et al. Portal glucose infusion increases hepatic glycogen deposition in conscious unrestrained rats. J Appl Physiol. 1999;87:1470–5.PubMed
17.
Zurück zum Zitat Burcelin R, Dolci W, Thorens B. Portal glucose infusion in the mouse induces hypoglycaemia: evidence that the hepatoportal glucose sensor stimulates glucose utilization. Diabetes. 2000;49:1635–42.PubMedCrossRef Burcelin R, Dolci W, Thorens B. Portal glucose infusion in the mouse induces hypoglycaemia: evidence that the hepatoportal glucose sensor stimulates glucose utilization. Diabetes. 2000;49:1635–42.PubMedCrossRef
18.
Zurück zum Zitat Pillot B, Soty M, Gautier-Stein A, Zitoun C, Mithieux G. Protein feeding promotes redistribution of endogenous glucose production to the kidney and potentiates its suppression by insulin. Endocrinology. 2009;150:616–24.PubMedCrossRef Pillot B, Soty M, Gautier-Stein A, Zitoun C, Mithieux G. Protein feeding promotes redistribution of endogenous glucose production to the kidney and potentiates its suppression by insulin. Endocrinology. 2009;150:616–24.PubMedCrossRef
19.
Zurück zum Zitat •• Hayes MT, Foo J, Besic V, et al. Is intestinal gluconeogenesis a key factor in the early changes in glucose homeosatasis following gastric bypass? Obes.Surg. 2011;21: 759–762. This is the first study addressing the question of IGNG shortly after gastric bypass surgery in humans. The experiments were performed 6 days after the operation, 8 hours after the last meal intake. Whereas the physiologic importance is difficult to evaluate from the parameters studied, a net release of glucose in the portal vein is reported in nondiabetic obese patients. PubMedCrossRef •• Hayes MT, Foo J, Besic V, et al. Is intestinal gluconeogenesis a key factor in the early changes in glucose homeosatasis following gastric bypass? Obes.Surg. 2011;21: 759–762. This is the first study addressing the question of IGNG shortly after gastric bypass surgery in humans. The experiments were performed 6 days after the operation, 8 hours after the last meal intake. Whereas the physiologic importance is difficult to evaluate from the parameters studied, a net release of glucose in the portal vein is reported in nondiabetic obese patients. PubMedCrossRef
20.
Zurück zum Zitat •• Svelikova E, Zahiragic S, Pieber TE, et al. Improved glucose metabolism early after gastric bypass surgery relies primarily on enhanced insulin sensitivity. Diabetologia. 2011;54 (Suppl1): S83. This is a relevant clinical study highlighting the role of the recovery of insulin sensitivity, rather than GLP-1 or insulin secretion, in the early improvements specific to gastric bypass. •• Svelikova E, Zahiragic S, Pieber TE, et al. Improved glucose metabolism early after gastric bypass surgery relies primarily on enhanced insulin sensitivity. Diabetologia. 2011;54 (Suppl1): S83. This is a relevant clinical study highlighting the role of the recovery of insulin sensitivity, rather than GLP-1 or insulin secretion, in the early improvements specific to gastric bypass.
21.
Zurück zum Zitat Mithieux G, Vidal H, Zitoun C, et al. Glucose-6 phosphatase mRNA and activity are increased to the same extent in kidney and liver of diabetic rats. Diabetes. 1996;45:891–6.PubMedCrossRef Mithieux G, Vidal H, Zitoun C, et al. Glucose-6 phosphatase mRNA and activity are increased to the same extent in kidney and liver of diabetic rats. Diabetes. 1996;45:891–6.PubMedCrossRef
22.
Zurück zum Zitat Mithieux G, Daniele N, Payrastre B, Zitoun C. Liver microsomal glucose-6 phosphatase is competitively inhibited by the lipid products of phosphatidyl-inositol 3-kinase. J Biol Chem. 1998;273:17–9.PubMedCrossRef Mithieux G, Daniele N, Payrastre B, Zitoun C. Liver microsomal glucose-6 phosphatase is competitively inhibited by the lipid products of phosphatidyl-inositol 3-kinase. J Biol Chem. 1998;273:17–9.PubMedCrossRef
23.
Zurück zum Zitat Daniele N, Rajas F, Payrastre B, et al. Phosphatidylinositol 3-kinase translocates onto liver endoplasmic reticulum and may account for the inhibition of glucose-6 phosphatase during refeeding. J Biol Chem. 1999;274:3597–601.PubMedCrossRef Daniele N, Rajas F, Payrastre B, et al. Phosphatidylinositol 3-kinase translocates onto liver endoplasmic reticulum and may account for the inhibition of glucose-6 phosphatase during refeeding. J Biol Chem. 1999;274:3597–601.PubMedCrossRef
24.
Zurück zum Zitat Minassian C, Mithieux G. Differential time course of liver and kidney glucose-6 phosphatase activity during fasting in rats. Comp Biochem Physiol. 1994;109B:99–104. Minassian C, Mithieux G. Differential time course of liver and kidney glucose-6 phosphatase activity during fasting in rats. Comp Biochem Physiol. 1994;109B:99–104.
25.
Zurück zum Zitat Minassian C, Zitoun C, Mithieux G. Differential time-course of liver and kidney glucose-6 phosphatase activity during long-term fasting in rat correlates with differential time-course of messenger RNA level. Mol Cell Biochem. 1996;155:37–41.PubMedCrossRef Minassian C, Zitoun C, Mithieux G. Differential time-course of liver and kidney glucose-6 phosphatase activity during long-term fasting in rat correlates with differential time-course of messenger RNA level. Mol Cell Biochem. 1996;155:37–41.PubMedCrossRef
26.
Zurück zum Zitat Mutel E, Abdul-Wahed A, Ramamonjisoa N, et al. Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type1 including development of multiple adenomas. J Hepatol. 2011;54:529–37.PubMedCrossRef Mutel E, Abdul-Wahed A, Ramamonjisoa N, et al. Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type1 including development of multiple adenomas. J Hepatol. 2011;54:529–37.PubMedCrossRef
27.
Zurück zum Zitat Mutel E, Gautier-Stein A, Abdul-Wahed A, et al. Control of blood glucose in the absence of hepatic glucose production during prolonged fasting in mice: induction of renal and intestinal gluconeogenesis by glucagon. Diabetes. 2011;Oct 19 [Epub ahead of print]. Mutel E, Gautier-Stein A, Abdul-Wahed A, et al. Control of blood glucose in the absence of hepatic glucose production during prolonged fasting in mice: induction of renal and intestinal gluconeogenesis by glucagon. Diabetes. 2011;Oct 19 [Epub ahead of print].
28.
Zurück zum Zitat • Penhoat A, Mutel E, Amigo-Correig M, et al. Protein-induced satiety is abolished in the absence of intestinal gluconeogenesis. Physiol Behav. 2011;105:89–93. This is unequivocal confirmation of the causal role of IGNG in the control of hunger sensation in mice. PubMedCrossRef • Penhoat A, Mutel E, Amigo-Correig M, et al. Protein-induced satiety is abolished in the absence of intestinal gluconeogenesis. Physiol Behav. 2011;105:89–93. This is unequivocal confirmation of the causal role of IGNG in the control of hunger sensation in mice. PubMedCrossRef
Metadaten
Titel
A Synergy between Incretin Effect and Intestinal Gluconeogenesis Accounting for the Rapid Metabolic Benefits of Gastric Bypass Surgery
verfasst von
Gilles Mithieux
Publikationsdatum
01.04.2012
Verlag
Current Science Inc.
Erschienen in
Current Diabetes Reports / Ausgabe 2/2012
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-012-0257-8

Weitere Artikel der Ausgabe 2/2012

Current Diabetes Reports 2/2012 Zur Ausgabe

Issues in the Nutritional Treatment of Type 2 Diabetes and Obesity (O Hamdy, Section Editor)

Transcultural Diabetes Nutrition Therapy Algorithm: The Asian Indian Application

Issues in the Nutritional Treatment of Type 2 Diabetes and Obesity (O Hamdy, Section Editor)

Diabetes-Specific Nutrition Algorithm: A Transcultural Program to Optimize Diabetes and Prediabetes Care

Pathogenesis of Type 2 Diabetes and Insulin Resistance (R Watanabe, Section Editor)

The Role of Toll-Like Receptors in Diabetes-Induced Inflammation: Implications for Vascular Complications

Issues in the Nutritional Treatment of Type 2 Diabetes and Obesity (O Hamdy, Section Editor)

Transculturalization of a Diabetes-Specific Nutrition Algorithm: Asian Application

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.